Ryuichiro Tsunematsu
About
In The Last Decade
Ryuichiro Tsunematsu
26 papers receiving 617 citations
Peers
Comparison fields: 5 of 58
- Obstetrics and Gynecology 310
- Reproductive Medicine 277
- Surgery 227
- Oncology 156
- Epidemiology 138
Countries citing papers authored by Ryuichiro Tsunematsu
This map shows the geographic impact of Ryuichiro Tsunematsu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ryuichiro Tsunematsu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ryuichiro Tsunematsu more than expected).
Fields of papers citing papers by Ryuichiro Tsunematsu
This network shows the impact of papers produced by Ryuichiro Tsunematsu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ryuichiro Tsunematsu. The network helps show where Ryuichiro Tsunematsu may publish in the future.
Co-authorship network of co-authors of Ryuichiro Tsunematsu
This figure shows the co-authorship network connecting the top 25 collaborators of Ryuichiro Tsunematsu. A scholar is included among the top collaborators of Ryuichiro Tsunematsu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ryuichiro Tsunematsu. Ryuichiro Tsunematsu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 9 | |
| 2 | 25 | |
| 3 | 28 | |
| 4 | 50 | |
| 5 | 85 | |
| 6 | 11 | |
| 7 | 16 | |
| 8 | 31 | |
| 9 | 11 | |
| 10 | 105 | |
| 11 | 16 | |
| 12 | 6 | |
| 13 | 37 | |
| 14 | Phase II dose escalation: a novel approach to balancing efficacy and toxicity of anticancer agents. Japanese Docetaxel Ovarian Cancer Study Group. | 7 |
| 15 | 17 | |
| 16 | 18 | |
| 17 | 50 | |
| 18 | 8 | |
| 19 | 52 | |
| 20 | Hormone dependency of a serially transplantable human breast cancer (Br-10) in nude mice. | 28 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.